PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+9.51%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$94.7M
AUM Growth
+$94.7M
(+6%)
Cap. Flow
+$936K
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9
Top Buys
| 1 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
$1.92M |
| 2 |
SkyWater Technology
SKYT
|
$995K |
| 3 |
8x8 Inc
EGHT
|
$901K |
| 4 |
Usio Inc
USIO
|
$467K |
| 5 |
Quest Diagnostics
DGX
|
$231K |
Top Sells
| 1 |
Gryphon Digital Mining
GRYP
|
$1.27M |
| 2 |
CareDx
CDNA
|
$969K |
| 3 |
UPH
UpHealth, Inc.
UPH
|
$415K |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$335K |
| 5 |
RingCentral
RNG
|
$221K |
Sector Composition
| 1 | Healthcare | 56.93% |
| 2 | Technology | 21.82% |
| 3 | Communication Services | 7.13% |
| 4 | Industrials | 6.74% |
| 5 | Consumer Staples | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $4.84M | 5.1% | 13,216 | – | – |
|
2
Idexx Laboratories
IDXX
$51.8B
| $4.41M | 4.65% | 10,805 | – | – |
|
3
Digi International
DGII
$1.29B
| $3.98M | 4.2% | 108,883 -1,550 | -1% | -$56.7K |
|
4
Microsoft
MSFT
$3.77T
| $3.68M | 3.88% | 15,326 | – | – |
|
5
Axogen
AXGN
$743M
| $3.06M | 3.23% | 307,040 +400 | +0.1% | +$3.99K |
|
6
Veracyte
VCYT
$2.39B
| $2.92M | 3.08% | 123,030 -500 | -0.4% | -$11.9K |
|
7
Abbott
ABT
$231B
| $2.91M | 3.07% | 26,480 -500 | -2% | -$54.9K |
|
8
Perion Network
PERI
$416M
| $2.7M | 2.85% | 106,571 -150 | -0.1% | -$3.8K |
|
|
AUGX
9
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $2.62M | 2.77% | 1,680,428 +1,233,528 | +276% | +$1.92M |
|
10
Pfizer
PFE
$141B
| $2.58M | 2.73% | 50,416 -800 | -2% | -$41K |
|
11
Natera
NTRA
$23.1B
| $2.49M | 2.63% | 61,900 -150 | -0.2% | -$6.03K |
|
|
STRM
12
DELISTED
Streamline Health Solutions
STRM
| $2.47M | 2.6% | 1,561,424 -60,216 | -4% | -$95.1K |
|
13
Alphatec Holdings
ATEC
$2.35B
| $2.26M | 2.38% | 182,717 -1,000 | -0.5% | -$12.4K |
|
14
TELA Bio
TELA
$70.5M
| $1.99M | 2.1% | 173,250 -500 | -0.3% | -$5.75K |
|
15
Ooma
OOMA
$356M
| $1.98M | 2.09% | 145,400 -650 | -0.4% | -$8.85K |
|
16
AbbVie
ABBV
$372B
| $1.88M | 1.98% | 11,608 | – | – |
|
17
NeoGenomics
NEO
$1.13B
| $1.83M | 1.93% | 197,700 +2,150 | +1% | +$19.9K |
|
18
LeMaitre Vascular
LMAT
$2.16B
| $1.73M | 1.83% | 37,586 -1,314 | -3% | -$60.5K |
|
19
OptimizeRx
OPRX
$335M
| $1.71M | 1.81% | 101,763 +200 | +0.2% | +$3.36K |
|
20
General Mills
GIS
$26.4B
| $1.7M | 1.8% | 20,325 | – | – |
|
21
Advanced Micro Devices
AMD
$264B
| $1.66M | 1.76% | 25,684 | – | – |
|
|
PFIE
22
DELISTED
Profire Energy, Inc
PFIE
| $1.52M | 1.6% | 1,429,830 -23,685 | -2% | -$25.1K |
|
23
AtriCure
ATRC
$1.84B
| $1.48M | 1.56% | 33,350 -1,000 | -3% | -$44.4K |
|
24
Magnite
MGNI
$3.7B
| $1.44M | 1.52% | 136,075 | – | – |
|
25
Merck
MRK
$210B
| $1.32M | 1.4% | 11,925 | – | – |
|